ClinicalTrials.gov
public full text
Public Domain
Matching Patients With Hematologic Malignancy to Adequate Clinical Trials
A molecular profile of a patient with hematologic malignancy, for whom standard-of-care had failed, is identified using next generation sequencing. Patients are assigned to early clinical trials of targeted agent based on the molecular profiling or physician's choice. The improvement of outcomes in the intention-to-treat population is investigated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer#1101167
- Real-world clinical utility of tumor whole-genome sequencing in solid cancers.#125627
- Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients#849730
- A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB#1173320
- Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia#1031402
Record · ID 831977
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive